| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/21/1998 | US5741492 Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
| 04/21/1998 | US5741490 Immunogenic composition comprising peptide containing carboxy-terminal amino acids of capsid protein encoded by second open reading frame of hepatitis e virus genome, carrier |
| 04/21/1998 | US5741489 Passively administered antibody that enhances feed conversion efficiency |
| 04/21/1998 | US5741488 Treatment of rheumatoid arthritis with anti-CD4 antibodies in conjunction with anti-TNF antibodies |
| 04/21/1998 | CA1339830C Human monoclonal antibody to lymphadenopathy associated virus |
| 04/21/1998 | CA1339828C Protective synthetic peptide against malaria and encoding gene |
| 04/16/1998 | WO1998015658A1 Compositions and methods for treating viral infections |
| 04/16/1998 | WO1998015637A1 Herpes simplex virus strains |
| 04/16/1998 | WO1998015632A1 A human protein tyrosine kinase |
| 04/16/1998 | WO1998015631A1 Attenuated microorganism strains expressing hpv proteins |
| 04/16/1998 | WO1998015626A2 Mutant ciita molecule and uses thereof |
| 04/16/1998 | WO1998015616A1 Methods for generating cytotoxic t cells in vitro |
| 04/16/1998 | WO1998015615A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | WO1998015580A1 Monoclonal antibodies against a human act and serine protease complex |
| 04/16/1998 | WO1998015579A1 Dendritic cell-specific antibodies |
| 04/16/1998 | WO1998015578A1 Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same |
| 04/16/1998 | WO1998015576A1 Platelet secretory transport protein |
| 04/16/1998 | WO1998015348A1 Microencapsulation process using supercritical fluids |
| 04/16/1998 | WO1998015288A1 Vaccine composition containing as additive a sympathomimetic compound |
| 04/16/1998 | WO1998015287A1 Vaccines |
| 04/16/1998 | WO1998015286A1 Carbohydrate-specific cytolytic t cells |
| 04/16/1998 | WO1998015285A1 Methods and compositions for inducing a protective immune response to cancers |
| 04/16/1998 | WO1998015284A2 Mycosis vaccines |
| 04/16/1998 | WO1998015282A1 Immunogenic tlp composition |
| 04/16/1998 | WO1998011229A3 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
| 04/16/1998 | DE4244894C2 New compsns. for vaccination against tumours and auto-immune disorders |
| 04/16/1998 | DE19641560A1 Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease Monoclonal antibodies against a complex of human ACT and a serine protease |
| 04/16/1998 | DE19641466A1 Orale Anwendung eines Immunglobulinpräparates zur Prävention des Hämolytischen Urämischen Syndroms sowie Präparat hierfür Oral administration of an immunoglobulin preparation for the prevention of hemolytic uremic syndrome and preparation thereof |
| 04/16/1998 | CA2269090A1 Methods for generating cytotoxic t cells in vitro |
| 04/16/1998 | CA2268284A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | CA2268283A1 Attenuated microorganism strains expressing hpv proteins |
| 04/16/1998 | CA2267905A1 Immunogenic tlp composition |
| 04/16/1998 | CA2267660A1 Monoclonal antibodies against a complex composed of human act and a serine protease |
| 04/16/1998 | CA2267646A1 Platelet secretory transport protein |
| 04/16/1998 | CA2267350A1 Microencapsulation process using supercritical fluids |
| 04/16/1998 | CA2267191A1 Vaccines |
| 04/16/1998 | CA2266424A1 A human protein tyrosine kinase |
| 04/16/1998 | CA2255939A1 Herpes simplex virus strains |
| 04/15/1998 | EP0835939A2 Fusion proteins with parts of immunoglobulins, their production and use |
| 04/15/1998 | EP0835938A2 Topoisomerase I |
| 04/15/1998 | EP0835936A2 Arginyl tRNA synthase |
| 04/15/1998 | EP0835933A2 A G-protein coupled receptor, HLTEX11 |
| 04/15/1998 | EP0835930A1 European vaccine strains of the porcine reproductive and respiratory syndrome virus (PRRSV) |
| 04/15/1998 | EP0835929A1 New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process |
| 04/15/1998 | EP0835928A1 Helicobacter pylori live vaccine |
| 04/15/1998 | EP0835880A1 Process for producing an IgM preparation for intravenous administration |
| 04/15/1998 | EP0835663A2 Combined vaccines comprising Hepatitis B surface antigen and other antigens |
| 04/15/1998 | EP0835318A2 Vaccines against hepatitis c |
| 04/15/1998 | EP0835315A1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 04/15/1998 | EP0835314A1 Immunogenic detoxified mutant of cholera toxins |
| 04/15/1998 | EP0835313A1 Omp26 antigen from haemophilus influenzae |
| 04/15/1998 | EP0835312A2 Recombinant mistletoe lectin |
| 04/15/1998 | EP0835309A2 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 04/15/1998 | EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 04/15/1998 | EP0835266A1 Modified/chimeric superantigens and their use |
| 04/15/1998 | EP0835135A2 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 04/15/1998 | EP0835133A1 Recombinant poxvirus-rabies compositions and combination compositions and uses |
| 04/15/1998 | EP0835132A1 Novel recombinant temperature sensitive mutants of influenza |
| 04/15/1998 | EP0835131A1 cDNA CLONE FOR SOUTH AFRICAN ARBOVIRUS NO. 86 |
| 04/15/1998 | EP0835130A1 Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins |
| 04/15/1998 | EP0835124A1 Serum preparations for inhibiting retroviruses and tumor growth |
| 04/15/1998 | EP0835122A1 Latent transcripts and promoters of cytomegalovirus |
| 04/15/1998 | CN1179181A GnRH-leukotoxin chimeras |
| 04/15/1998 | CN1178703A Gastrointestinal tract preparation for bady and its producing technology |
| 04/15/1998 | CN1038035C Preparing method for polyethylene protein conjugates |
| 04/14/1998 | US5739323 Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies |
| 04/14/1998 | US5739292 HCMV/HSV fusion glycoproteins |
| 04/14/1998 | US5739274 Comprising polypeptide linked to phospholipid; produces delayed increase in blood pressure, increase in extracellular calcium uptake by vascular smooth muscle |
| 04/14/1998 | US5739118 Compositions and methods for delivery of genetic material |
| 04/14/1998 | US5739116 Enediyne derivatives useful for the synthesis of conjugates of methyltrithio antitumor agents |
| 04/14/1998 | US5739032 Isolated nucleic acid encodes a glycoprotein for treating leukocyte adhesion deficiency |
| 04/14/1998 | US5739026 DNA expression systems based on alphaviruses |
| 04/14/1998 | US5739009 Adipocyte-specific differentiation-related protein |
| 04/14/1998 | US5738867 Antigen encapsulated or conjugated to liposome carrier; antitumor agents |
| 04/14/1998 | US5738855 O-acetylating a plant, fruit or synthetic oligo or polygalacturonate, conjugating the modified plant, fruit or poly or oligogalacturonate to a carrier which is immunogenic against salmonella typhi |
| 04/14/1998 | US5738853 Human papillomaviruses and mutants which code for proteins |
| 04/14/1998 | US5738852 Methods of enhancing antigen-specific T cell responses |
| 04/14/1998 | US5738844 Polypeptides |
| 04/09/1998 | WO1998014596A2 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | WO1998014593A2 Human telomerase catalytic subunit |
| 04/09/1998 | WO1998014592A2 Telomerase reverse transcriptase |
| 04/09/1998 | WO1998014586A1 A polynucleotide herpes virus vaccine |
| 04/09/1998 | WO1998014585A1 Nucleocapsid gene of seoul virus r22, recombinant plasmid, transformed e. coli and diagnostic agent and vaccine for haemorrhagic fever with renal syndrome |
| 04/09/1998 | WO1998014584A2 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
| 04/09/1998 | WO1998014583A2 Method for producing recombinants intended for use in a complete malaria antigene gp190/msp1 |
| 04/09/1998 | WO1998014580A1 Reconstituted human anti-hm1.24 antibody |
| 04/09/1998 | WO1998014572A1 Novel human phospholemman-like protein |
| 04/09/1998 | WO1998014564A1 Synthetic hpv16 virus-like particles |
| 04/09/1998 | WO1998014563A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
| 04/09/1998 | WO1998014480A1 G protein-coupled receptor antagonists |
| 04/09/1998 | WO1998014464A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 04/09/1998 | WO1998014463A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF |
| 04/09/1998 | WO1998014461A1 NOVEL spsB |
| 04/09/1998 | WO1998014217A1 Methods and means for the treatment of malignancies |
| 04/09/1998 | WO1998014216A2 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 04/09/1998 | WO1998014212A1 Method of producing active immunity with vaccine conjugate |
| 04/09/1998 | WO1998014211A1 Pharmaceutical products containing protein-tyrosine kinase inhibitors and anti-cd4 antibodies |
| 04/09/1998 | WO1998014210A1 Method for treating allergic lung disease |
| 04/09/1998 | WO1998014209A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | WO1998014207A1 Immunological therapy for cancer |